In the present report, we conducted an investigation combining IR spectral histopathology (IRSH), conventional histology and immunohistochemistry to study the effect of lumican-derived peptide (L9Mc) on tumor progression in melanoma primary tumors. The gene discussed is LUM; the disease is melanoma.